149 related articles for article (PubMed ID: 26501139)
1. miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.
Li J; Yao L; Li G; Ma D; Sun C; Gao S; Zhang P; Gao F
PLoS One; 2015; 10(10):e0141168. PubMed ID: 26501139
[TBL] [Abstract][Full Text] [Related]
2. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
[TBL] [Abstract][Full Text] [Related]
3. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
5. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
[TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
[TBL] [Abstract][Full Text] [Related]
7. Timeless-Stimulated miR-5188-FOXO1/β-Catenin-c-Jun Feedback Loop Promotes Stemness via Ubiquitination of β-Catenin in Breast Cancer.
Zou Y; Lin X; Bu J; Lin Z; Chen Y; Qiu Y; Mo H; Tang Y; Fang W; Wu Z
Mol Ther; 2020 Jan; 28(1):313-327. PubMed ID: 31604679
[TBL] [Abstract][Full Text] [Related]
8. MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition.
Tang J; Li L; Huang W; Sui C; Yang Y; Lin X; Hou G; Chen X; Fu J; Yuan S; Li S; Wen W; Tang S; Cao D; Wu M; Chen L; Wang H
Cancer Lett; 2015 Aug; 364(1):33-43. PubMed ID: 25931210
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN.
Chen J; Yan D; Wu W; Zhu J; Ye W; Shu Q
Oncol Rep; 2016 Jun; 35(6):3285-92. PubMed ID: 27035216
[TBL] [Abstract][Full Text] [Related]
11. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
12. microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway.
Liu Z; Wang J; Guo C; Fan X
Biomed Pharmacother; 2015 Feb; 69():24-8. PubMed ID: 25661333
[TBL] [Abstract][Full Text] [Related]
13. miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer.
Yanaka Y; Muramatsu T; Uetake H; Kozaki K; Inazawa J
Carcinogenesis; 2015 Nov; 36(11):1363-71. PubMed ID: 26264654
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist.
Li B; Han Q; Zhu Y; Yu Y; Wang J; Jiang X
FEBS J; 2012 Jul; 279(13):2393-8. PubMed ID: 22540680
[TBL] [Abstract][Full Text] [Related]
15. Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM.
Li W; Miao X; Liu L; Zhang Y; Jin X; Luo X; Gao H; Deng X
Oncotarget; 2017 Apr; 8(15):25167-25176. PubMed ID: 28445937
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
17. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
Lei L; Huang Y; Gong W
Oncol Rep; 2013 Dec; 30(6):2897-902. PubMed ID: 24084898
[TBL] [Abstract][Full Text] [Related]
18. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer.
Ghahhari NM; Babashah S
Eur J Cancer; 2015 Aug; 51(12):1638-49. PubMed ID: 26025765
[TBL] [Abstract][Full Text] [Related]
19. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
Xiong B; Cheng Y; Ma L; Zhang C
Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
[TBL] [Abstract][Full Text] [Related]
20. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
Luo Z; Zhang L; Li Z; Jiang C; Dai Y; Liu X; Zheng Y; Yu H; Xiang J; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):604-9. PubMed ID: 21873783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
